Skip to main content
Fig. 3 | Biomarker Research

Fig. 3

From: Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Fig. 3

CITE-Seq clustering analysis according to time-point sampling. a PCA analysis unsupervised clustering; b UMAP representation of clusters; c, d, e UMAP representation and quantification of cellular populations (% cells with absolute numbers above bars) before treatment (M0) (c), at response-time (M3) (d); during progression (M27) (e)

Back to article page